SPONSOR

Tongji Hospital

Total Trials

Recruiting

Phases

EARLY_Phase 1, Phase 2

Conditions studied: Cranial Diseases (e.g., Brain Tumors, Stroke, Neurodegenerative Disorders)Postoperative Complications Thoracic Surgery Perioperative Monitoring Ischemic Stroke Ischemic Cerebrovascular Disease Etomidate Combined With Propofol Hypertension Lupus Nephritis IgG4-related Disease

Tongji Hospital is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Cranial Diseases (e.g., Brain Tumors, Stroke, Neurodegenerative Disorders), Postoperative Complications, Thoracic Surgery, Perioperative Monitoring.

The trial portfolio spans EARLY_Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Tongji Hospital

How many clinical trials has Tongji Hospital sponsored?

ClinicalMetric currently tracks 15 clinical trials sponsored by Tongji Hospital, of which 15 are actively recruiting participants. These trials cover conditions including Cranial Diseases (e.g., Brain Tumors, Stroke, Neurodegenerative Disorders), Postoperative Complications, Thoracic Surgery. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Tongji Hospital research focus on?

Tongji Hospital clinical trials span Cranial Diseases (e.g., Brain Tumors, Stroke, Neurodegenerative Disorders), Postoperative Complications, Thoracic Surgery, Perioperative Monitoring, Ischemic Stroke, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Tongji Hospital clinical trial?

To participate in a Tongji Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tongji Hospital trials with current recruitment status updated daily.

Tongji Hospital

Frequently Asked Questions — Tongji Hospital

Clinical Trials by Tongji Hospital

Construction of AI Model for Precision Imaging Diagnosis of Cranial Diseases

Wearable Device-Based Early Warning of Postoperative Complications in Thoracic Surgery

Clinical Evaluation of New Biomarkers for Ischemic Cerebrovascular Disease

Safety of Etomidate-propofol Mixture vs. Propofol for Total Intravenous Anesthesia in Elderly Patients Undergoing Abdominal Surgery

Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease

Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment

PEG Laxatives for Intestinal Preparation and Gut Microbiota in Cholecystectomy

Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance

The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus

Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing

Headache Registration and Followup Initiated by Tongji Hospital, HUST

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)

Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer